Search all trials

Find therapies in clinical trials near you – page 8

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Lupus nephritis

Not recruiting

Registered drug

Study on the Effects of Ianalumab with Standard Therapy for Patients with Active Lupus Nephritis

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Emtricitabine

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study on Adding Isatuximab to Lenalidomide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Acute myeloid leukaemia+1

Not recruiting

Registered drugNo placebo

Study Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Gilteritinib

Contact Research Centre

Gastrooesophageal cancer+1

Not recruiting

Registered drugNo placebo

Study on Organ Preservation for Early Stage Esophageal Cancer Using Durvalumab and Chemoradiation for Patients Eligible for Surgery

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Docetaxel

Contact Research Centre

Gastrooesophageal cancer

Not recruiting

Registered drugNo placebo

Study on Atezolizumab with Drug Combination for Patients with Gastric Cancer and Esophagogastric Junction Adenocarcinoma

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Idiopathic inflammatory myopathy

Not recruiting

Investigational

Study on the Effects and Safety of Efgartigimod PH20 SC for Adults with Active Idiopathic Inflammatory Myopathy

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Efgartigimod Alfa

Contact Research Centre

Axial spondyloarthritis

Not recruiting

Registered drugNo placebo

Study on the Effects of Risankizumab in Patients with Very Early Axial Spondyloarthritis

Registered drugNo placebo

Germany

Participants:18–64 years
Substances:Risankizumab

Contact Research Centre

B-cell lymphoma refractory

Not recruiting

Registered drugNo placebo

Study on Tafasitamab with Gemcitabine, Oxaliplatin, and Rituximab for Patients with Aggressive B-cell Lymphoma

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Oxaliplatin

Contact Research Centre

Giant cell arteritis

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Secukinumab for Patients with New-Onset Giant Cell Arteritis in Clinical Remission

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Secukinumab

Contact Research Centre

Systemic lupus erythematosus+3

Not recruiting

Registered drugNo placebo

Study on the Effects of Ianalumab in Adults with Rheumatoid Arthritis, Systemic Lupus Erythematosus, or Sjögren’s Disease

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Emtricitabine

Contact Research Centre

Adenocarcinoma gastric+1

Not recruiting

Registered drugNo placebo

Study Comparing Ramucirumab with Irinotecan, Leucovorin, and 5-FU or Paclitaxel for Patients with Advanced Stomach or Gastroesophageal Cancer After Previous Chemotherapy

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Calcium Folinate

Contact Research Centre

Polymyalgia rheumatica

Not recruiting

Registered drug

Study of Prednisolone and SPI-62 for Patients with Polymyalgia Rheumatica

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Clofutriben

Contact Research Centre

Find therapies in clinical trials near you – page 8

137 trials match your criteria

Lupus nephritis

Study on the Effects of Ianalumab with Standard Therapy for Patients with Active Lupus Nephritis

Plasma cell myeloma

Study on Adding Isatuximab to Lenalidomide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma

Acute myeloid leukaemia+1

Study Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation

Gastrooesophageal cancer+1

Study on Organ Preservation for Early Stage Esophageal Cancer Using Durvalumab and Chemoradiation for Patients Eligible for Surgery

Gastrooesophageal cancer

Study on Atezolizumab with Drug Combination for Patients with Gastric Cancer and Esophagogastric Junction Adenocarcinoma

Idiopathic inflammatory myopathy

Study on the Effects and Safety of Efgartigimod PH20 SC for Adults with Active Idiopathic Inflammatory Myopathy

Axial spondyloarthritis

Study on the Effects of Risankizumab in Patients with Very Early Axial Spondyloarthritis

B-cell lymphoma refractory

Study on Tafasitamab with Gemcitabine, Oxaliplatin, and Rituximab for Patients with Aggressive B-cell Lymphoma

Giant cell arteritis

Study on the Effectiveness and Safety of Secukinumab for Patients with New-Onset Giant Cell Arteritis in Clinical Remission

Systemic lupus erythematosus+3

Study on the Effects of Ianalumab in Adults with Rheumatoid Arthritis, Systemic Lupus Erythematosus, or Sjögren’s Disease

Adenocarcinoma gastric+1

Study Comparing Ramucirumab with Irinotecan, Leucovorin, and 5-FU or Paclitaxel for Patients with Advanced Stomach or Gastroesophageal Cancer After Previous Chemotherapy

Polymyalgia rheumatica

Study of Prednisolone and SPI-62 for Patients with Polymyalgia Rheumatica

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.